Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02951104 · ClinicalTrials.gov registry record · NA

Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension

A NA study of Pulmonary Hypertension, sponsored by Santa Barbara Cottage Hospital.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT02951104: Completed NA study of Pulmonary Hypertension, sponsored by Santa Barbara Cottage Hospital.

NCT02951104 is a NA study of Pulmonary Hypertension that has completed, run by Santa Barbara Cottage Hospital. The registered enrollment target is 35 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02951104, a NA study of Pulmonary Hypertension, has completed, sponsored by Santa Barbara Cottage Hospital.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

Comparison of Ultrasonic Cardiac Output Monitor (USCOM) system with Fick and thermodilution methods during right heart catheterization in patients with pulmonary hypertension.

Primary Outcome

Correlation between cardiac output measurement between USCOM system and Fick and thermodilution methods of cardiac output measurement (standard of care)

Conditions Studied

Interventions

  • DEVICE Ultrasonic Cardiac Output Monitor (USCOM) system

Study Locations (1)

California

  • Santa Barbara Cottage Hospital - Santa Barbara

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-11
Est. Completion 2021-10
Phase NA
Santa Barbara Cottage Hospital

4 total trials

What the finished NCT02951104 record still lists

NCT02951104 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Ultrasonic Cardiac Output Monitor (USCOM) system is the first listed.

NCT02951104 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02951104 about?

NCT02951104 is a clinical study titled "Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension". Comparison of Ultrasonic Cardiac Output Monitor (USCOM) system with Fick and thermodilution methods during right heart catheterization in patients with pulmonary hypertension.

What is the current status of trial NCT02951104?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-11. Estimated completion is 2021-10.

What conditions does trial NCT02951104 study?

This clinical trial studies the following conditions: Pulmonary Hypertension.

What interventions are being tested in trial NCT02951104?

The interventions under investigation include: Ultrasonic Cardiac Output Monitor (USCOM) system (DEVICE).

Who is sponsoring clinical trial NCT02951104?

This trial is sponsored by Santa Barbara Cottage Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02951104 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02951104's enrollment target sits among peer trials

35 46th of 72 higher than 27 of 72 other Pulmonary Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02951104, the US trial registry maintained by the National Library of Medicine. NCT02951104 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.